Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy-Reference-Cited by-同舟云学术

Biotechnology and genetic engineering in the new drug development. Part II. Monoclonal antibodies, modern vaccines and gene therapy

Published:2013-09 Issue:5 Volume:65 Page:1086-1101
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Stryjewska Agnieszka,Kiepura Katarzyna,Librowski Tadeusz,Lochyński Stanisław

Funder

Biotransformation for pharmaceutical and cosmetic industry

European Union within the European Regional Development Fund

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference54 articles.

1. Large scale production and characterization of anti-human IgG monoclonal antibody in peritoneum of Balb/c mice;Abdolalizadeh;Am J Biochem Biotechnol,2005

2. Applied biocatalysis.;Adlercreutz,2005

3. Adenovirus p16 gene therapy for prostate cancer;Allay;World J Urol,2000

4. Old and new vaccine approaches;Arnon;Int Immunopharmacol,2003

5. Toward a science of metabolic engineering;Bailey;Science,1991

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Monoclonal Antibodies with Natural Products: Mechanisms and Applications;Intelligent Pharmacy;2024-09

2. Biotechnology executive order opens door for regulatory reform and social acceptance of genetically engineered microbes in agriculture;GM Crops & Food;2024-07-27

3. Gene transfer to the vascular system: Novel translational perspectives for vascular diseases;Biochemical Pharmacology;2020-12

4. Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies;Antibodies;2019-03-05

5. Obtaining and characterization of anti-testis monoclonal antibodies: Invaluable tools toward the identification of testis antigens involved in fertilization;Human Antibodies;2018-08-20